Topical provocation in fixed drug eruption from nonsteroidal anti-inflammatory drugs

Exogenous Dermatology

Volumn 1, Issue 2, 2002, Pages 81-86

  Gonçalo, Margarida ^a   Oliveira, Hugo S ^a   Fernandes, Bárbara ^a   Robalo Cordeiro, Margarida ^a   Figueiredo, Américo ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Drug eruption; Feprazone; Fixed drug eruption; Lesional patch testing; Nimesulide; Nonsteroidal anti inflammatory drugs (NSAID); Piroxicam; Tenoxicam; Topical provocation

Indexed keywords

DICLOFENAC; FENTIAZAC; FEPRAZONE; FLURBIPROFEN; INDOMETACIN; JABASULIDE; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; PIROXICAM BETA CYCLODEXTRIN; REUMOXICAM; TENOXICAM; THIOSALICYLIC ACID;

ADULT; AGED; ARTICLE; BLISTER; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PAPULE; PATCH TEST; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROVOCATION TEST; SKIN BIOPSY; SKIN EDEMA; SKIN MANIFESTATION; ULTRAVIOLET A RADIATION;

EID: 0037499739     PISSN: 14244616     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058337     Document Type: Article

References (18)

1. Kauppinen K, Stubb S: Fixed drug eruptions: Causative drugs and challenge tests. Br J Dermatol 1985;112:575-578.
2. Mahboob A, Haroon TS: Drugs causing fixed drug eruptions: A study of 450 cases. Int J Dermatol 1998;38:833-838.
3. Lee AY: Topical provocation in 31 cases of fixed drug eruption: Change of the causative drugs in 10 years. Contact Dermatitis 1998;38:258-260.
4. Alanko K, Stubb S, Reitamo S: Topical provocation of fixed drug eruption. Br J Dermatol 1987;116:561-567.
5. Alanko K: Topical provocation of fixed drug eruption - A study of 30 patients. Contact Dermatitis 1994;31:25-27.
6. Oliveira HS, Gongalo M, Reis JP, Figueiredo A: Fixed drug eruption to piroxicam: Positive patch tests with cross-sensitivity to tenoxicam. J Dermatol Treatment 1999;10:209-212.
7. Cordeiro MR, Gonçalo M, Fernandes B, Oliveira H, Figueiredo A: Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Dermatitis 2000:43:307.
8. Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F, Royer RJ: Adverse drug reaction monitoring: Doing it the French way. Lancet 1985;ii:1056-1058.
9. Barbaud A, Reichert-Penetral: S, Tréchot P, Jacquin-Petit MA, Ehlinger A, Noirez V, Faure GC, Schmutz JL, Bene MC: The use of kin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
10. Infarmed (Ministério da Saúde): Informação terapêutica 1999;3:7-8.
11. Gruppo Italiano Studi Epidemiologici in Dermatología (GISED): Cutaneous reactions to analgesics, antipyretics and nonsteroidal anti-inflammatory drugs. Dermatology 1993;186:164-169.
12. Valsecchi R, Cainelli T: Nonpigmenting fixed drug reaction to piroxicam. J Am Acad Dermatol 1989;21:1300.
13. Stubb S, Reitamo S: Fixed drug eruption caused by piroxicam. J Am Acad Dermatol 1990;22:1111-1112.
14. de la Hoz B, Soria C, Fraj J, Losada E, Ledo A: Fixed drug eruption due to piroxicam. Int J Dermatol 1990;29:672-673.
15. Gastaminza G, Echechipia S, Navarro JA, Fernandez de Corres L: Fixed drug eruption from piroxicam. Contact Dermatitis 1993;28:43-44.
16. Ordoqui E, de Barrio M, Rodriguez VM, Herrero T, Gil PJ, Baeza ML: Cross-sensitivity among oxicams in piroxicam-caused fixed drug eruption: Two case reports. Allergy 1995;50:741-744.
17. Gonçalo M, Figueiredo A, Tavares P, Ribeiro CA, Teixeira F, Baptista AP: Photosensitivity to piroxicam: Absence of cross-reaction with tenoxicam. Contact Dermatitis 1992;27:287-290.
18. Figueiredo A, Gonçalo M, Tavares P, Fontes Ribeiro CA, Teixeira F, Poiares Baptista A: Pathophysiology of photosensitivity to piroxicam. J Eur Acad Dermatol Venereol 1995;5:S90.